Autolus Therapeutics plc

AUTLNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$75.4M

▲ 644.9% YoY

Net Income

-$287.5M

▼ 30.3% YoY

EPS

$-1.08

▼ 25.6% YoY

Cash

$104.1M

▼ 54.2% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.